Literature DB >> 9076650

Pregnancy and addiction. A comprehensive care model.

L M Jansson1, D Svikis, J Lee, P Paluzzi, P Rutigliano, F Hackerman.   

Abstract

The problem of substance abuse in pregnancy is a major public health dilemma. Effective comprehensive care of drug addicted women has been shown to improve maternal and neonatal outcomes. The Center for Addiction and Pregnancy (CAP) combines the disciplines of pediatrics, substance abuse treatment, obstetrics/gynecology, and family planning in an effort to reduce the barriers to care often presenting in this subpopulation. For the first 100 CAP births, 82% were delivered vaginally, with a mean gestational age of 38 weeks. The Neonatal Intensive Care Unit admission rate was 10%, and the Bayley Scales of Infant Development performed at 6 and 12 months revealed mean developmental indices within the normal range. In a comparison study, a group of CAP participants had nearly $5,000 savings in costs when compared to a matched cohort. The CAP model of care appears to be an effective mode of treatment for substance abusing pregnant women.

Entities:  

Mesh:

Year:  1996        PMID: 9076650     DOI: 10.1016/s0740-5472(96)00070-0

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  53 in total

1.  Weekly patterns of drug treatment attendance.

Authors:  D S Svikis; R W Pickens; W Schweitzer; E Johnson; N Haug
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

Review 2.  Drug misusing parents: key points for health professionals.

Authors:  J Keen; L H Alison
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 3.  Monetary-based consequences for drug abstinence: methods of implementation and some considerations about the allocation of finances in substance abusers.

Authors:  Jesse Dallery; Bethany Raiff
Journal:  Am J Drug Alcohol Abuse       Date:  2011-12-13       Impact factor: 3.829

Review 4.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 5.  Substance abuse treatment entry, retention, and outcome in women: a review of the literature.

Authors:  Shelly F Greenfield; Audrey J Brooks; Susan M Gordon; Carla A Green; Frankie Kropp; R Kathryn McHugh; Melissa Lincoln; Denise Hien; Gloria M Miele
Journal:  Drug Alcohol Depend       Date:  2006-06-08       Impact factor: 4.492

6.  Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment.

Authors:  Brandi Jancaitis; Sydney Kelpin; Saba Masho; James May; Nancy A Haug; Dace Svikis
Journal:  Women Health       Date:  2019-05-08

7.  Exposure to violence among substance-dependent pregnant women and their children.

Authors:  Martha L Velez; Ivan D Montoya; Lauren M Jansson; Vickie Walters; Dace Svikis; Hendree E Jones; Howard Chilcoat; Jacquelyn Campbell
Journal:  J Subst Abuse Treat       Date:  2006-01

8.  Concentrations of methadone in breast milk and plasma in the immediate perinatal period.

Authors:  Lauren M Jansson; Robin E Choo; Cheryl Harrow; Martha Velez; Jennifer R Schroeder; Ross Lowe; Marilyn A Huestis
Journal:  J Hum Lact       Date:  2007-05       Impact factor: 2.219

9.  Maternal buprenorphine treatment and infant outcome.

Authors:  Lauren M Jansson; Martha L Velez; Krystle McConnell; Nancy Spencer; Michelle Tuten; Hendree Jones; Rebeca Rios; Van L King; Neeraj Gandotra; Lorraine Millio; Janet A DiPietro
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

10.  The efficacy of escalating and fixed contingency management reinforcement on illicit drug use in opioid-dependent pregnant women.

Authors:  Melissa L Hutchinson; Margaret S Chisolm; Michelle Tuten; Jeannie-Marie S Leoutsakos; Hendrée E Jones
Journal:  Addict Disord Their Treat       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.